The global clinical nutrition market reached USD 55.8 billion in 2024 and is forecast to surge to USD 104.6 billion by 2033, growing at a CAGR of 7.2%. This growth is fuelled by rising chronic disease prevalence, technological breakthroughs in personalized and medical nutrition, ageing demographics, and changing dietary habits - all of which are promoting awareness and demand for clinical nutrition solutions.
STUDY ASSUMPTION YEARS
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019–2024
- FORECAST YEAR: 2025–2033
CLINICAL NUTRITION MARKET KEY TAKEAWAYS
- Asia‑Pacific holds the largest regional market share, supported by rising chronic disease burden and expanding healthcare access.
- Infant nutrition remains the top product segment, fulfilling early developmental dietary needs.
- Oral administration leads the route segment due to convenience, safety, and broad acceptance.
- Application-wise, cancer-related nutrition support and malnutrition interventions are fuelling adoption.
- Pediatric end-users dominate demand, driven by high child populations and targeted nutritional formulations.
- Market growth: from USD 55.8 B in 2024 to USD 104.6 B by 2033, at 7.2% CAGR.
MARKET GROWTH FACTORS
- Growing Demand for Clinical Nutrition in Hospitals and Clinics
The Clinical Nutrition Market is expanding as hospitals and clinics increasingly adopt nutritional products to support patient recovery and treatment outcomes. With rising cases of chronic diseases, malnutrition, and post-surgical recovery needs, healthcare providers emphasize specialized nutrition for faster healing. Clinical nutrition supplements, both enteral and parenteral, play a key role in improving immunity, stabilizing health, and reducing hospitalization periods. Hospitals also prefer evidence-based nutrition therapy to meet regulatory and patient care standards. Furthermore, advanced formulations designed for intensive care patients, cancer patients, and those with digestive disorders are boosting demand. As healthcare systems worldwide focus on lowering treatment costs while improving patient well-being, clinical nutrition products are gaining higher acceptance in medical institutions, strengthening their market growth globally.
- Rising Prevalence of Lifestyle-Related Diseases Driving Demand
The Clinical Nutrition Market is benefiting from the global surge in lifestyle-related disorders such as diabetes, obesity, cardiovascular diseases, and gastrointestinal problems. Patients with such conditions require medically supervised nutrition plans that include high-protein, low-sugar, or disease-specific formulations. Clinical nutrition products are tailored to manage blood sugar levels, improve metabolic health, and provide essential nutrients often missing in restricted diets. As sedentary lifestyles and poor dietary habits spread globally, the burden of these chronic diseases continues to grow. Clinical nutrition helps improve treatment adherence and enhances quality of life for patients undergoing long-term medical care. This growing demand for specialized nutrition to complement medical treatments is significantly boosting the adoption of clinical nutrition across healthcare facilities and homes.
- Expanding Role of Clinical Nutrition in Cancer Care
The Clinical Nutrition Market is increasingly shaped by its critical role in oncology care. Cancer patients undergoing chemotherapy, radiation, or surgery often face appetite loss, nutrient deficiencies, and muscle wasting. Clinical nutrition products help maintain energy levels, preserve lean body mass, and support faster recovery during treatment. Nutritional interventions have been shown to improve survival rates and enhance treatment tolerance. Hospitals and oncology centers are prescribing disease-specific formulations that address protein-energy malnutrition and strengthen immunity. Furthermore, innovations in enteral and parenteral nutrition tailored for cancer patients are making therapies more effective. As global cancer incidence rises, clinical nutrition is becoming an essential component of supportive care, creating substantial growth opportunities in the market.
Request for a sample copy of this report:
https://www.imarcgroup.com/clinical-nutrition-market/requestsample
MARKET SEGMENTATION
Breakup by Product:
- Infant Nutrition: addresses the dietary needs of newborns with formula and supplements
- Parental Nutrition
- Enteral Nutrition
Breakup by Route of Administration:
- Oral
- Enteral
- Parenteral
Breakup by Application:
- Cancer
- Malnutrition
- Metabolic Disorders
- Gastrointestinal Disorders
- Neurological Disorders
- Others
Breakup by End User:
- Pediatric
- Adults
- Geriatric
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
REGIONAL INSIGHTS
Asia‑Pacific leads the clinical nutrition market, propelled by rapid urbanization, rising chronic disease incidence, and expanding geriatric populations in India and China. With improving healthcare access and higher disposable incomes, demand for specialized nutrition and preventive therapy continues to grow strongly.
RECENT DEVELOPMENTS & NEWS
Recent innovations include Nestlé Health Science’s 2023 partnership with EraCal Therapeutics to develop new nutraceuticals targeting metabolic diseases, reflecting a shift toward functional, health-focused foods. Danone’s May 2024 acquisition of U.S. tube‑feeding specialist Functional Formularies has bolstered its enteral nutrition portfolio and U.S. presence. Friesland Campina Ingredients released Nutri Whey™ ProHeat, a heat-stable whey protein for medical nutrition, showcasing cutting-edge ingredient innovation.
KEY PLAYERS
Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.
Ask Analyst for Customization:
https://www.imarcgroup.com/request?type=report&id=5995&flag=C
Mainframe Market: https://www.imarcgroup.com/mainframe-market
Transthyretin Amyloidosis Treatment Market: https://www.imarcgroup.com/transthyretin-amyloidosis-treatment-market
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)
